Your browser doesn't support javascript.
loading
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
Stagno, Fabio; Breccia, Massimo; Annunziata, Mario; Trawinska, Malgorzata Monika; Iurlo, Alessandra; Sgherza, Nicola; Fava, Carmen; Gozzini, Antonella; Luciano, Luigiana; Carmosino, Ida; Bonifacio, Massimiliano; Sorà, Federica; Leonetti Crescenzi, Sabrina; Crugnola, Monica; Gugliotta, Gabriele; Galimberti, Sara; Bucelli, Cristina; Colafigli, Gioia; Feo, Costanzo; Tiribelli, Mario; Mauro, Endri; Russo Rossi, Antonella; Guarini, Attilio; Abruzzese, Elisabetta; Rosti, Gianantonio; Di Raimondo, Francesco; Latagliata, Roberto.
Afiliação
  • Stagno F; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico Rodolico-San Marco, Catania, Italy.
  • Breccia M; Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
  • Annunziata M; Hematology Section, Cardarelli Hospital, Naples, Italy.
  • Trawinska MM; Hematology Section, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
  • Iurlo A; Hematology Section, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Sgherza N; Hematology Unit, IRCCS "Casa Sollievo Sofferenza" Hospital, San Giovanni Rotondo, Italy.
  • Fava C; Hematology Section, Azienda Ospedaliera Mauriziano, Turin, Italy.
  • Gozzini A; Hematology Section, Careggi Hospital, Florence, Italy.
  • Luciano L; Hematology Section, Federico II University, Naples, Italy.
  • Carmosino I; Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
  • Bonifacio M; Hematology Section, Department of Medicine, University of Verona, Verona, Italy.
  • Sorà F; Hematology Section, Policlinico A. Gemelli, IRCSS Catholic University, Rome, Italy.
  • Leonetti Crescenzi S; Hematology Section, Azienda Ospedaliera San Giovanni-Addolorata, Rome, Italy.
  • Crugnola M; Hematology Section and BMT Unit, AOU Parma, Parma, Italy.
  • Gugliotta G; Hematology Section "Seragnoli", IRCCS AOU Bologna, University of Bologna, Bologna, Italy.
  • Galimberti S; Hematology Section, University of Pisa, Pisa, Italy.
  • Bucelli C; Hematology Section, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Colafigli G; Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
  • Feo C; Immunohematology and Transfusion Unit, AORN "Gaetano Rummo", Benevento, Italy.
  • Tiribelli M; Hematology Section and BMT, University of Udine, Udine, Italy.
  • Mauro E; Hematology Section, Dipartimento di Medicina Specialistica, Ca' Foncello Hospital, Treviso, Italy.
  • Russo Rossi A; Unit of Hematology and Stem Cell Transplantation, AOU Policlinico, Bari, Italy.
  • Guarini A; Unit of Hematology and Cell Therapy, IRCCS-Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Abruzzese E; Hematology Section, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.
  • Rosti G; Hematology Section, IRCCS "Dino Amadori", Meldola, Italy.
  • Di Raimondo F; Hematology Section and BMT Unit, Rodolico Hospital, AOU Policlinico Rodolico-San Marco, Catania, Italy.
  • Latagliata R; Hematology Section, Belcolle Hospital, Viterbo, Italy.
Acta Oncol ; 60(11): 1527-1533, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34499575

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália